Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1553498
PUBLISHER: Grand View Research | PRODUCT CODE: 1553498
Southeast Asia Pacemakers Market Size, Share & Trends Analysis Report By Implant Product (Implantable, External), By Type (MRI Compatible, Conventional), By Application, By End-use, By Country, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 80 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Southeast Asia Pacemakers Market Growth & Trends:
The Southeast Asia pacemakers market size is expected to reach USD 97.67 million by 2030 and is projected to grow at a CAGR of 5.92 % from 2024 to 2030, according to a new report by Grand View Research, Inc. South East Asia is witnessing a significant demographic shift towards an older population. Older individuals are more susceptible to heart-related issues, which increases the need for pacemakers. This aging trend is accelerating the demand for devices that help manage heart rhythm disorders. Moreover, the increasing prevalence of cardiovascular diseases, such as arrhythmias and heart block, is a major driver for the market.
A report from the National Library of Medicine published in April 2024 highlights significant variations in heart failure classifications across Southeast Asia. The INTER-CHF study reveals that 39% of heart failure patients in Malaysia and the Philippines have a reduced left ventricular ejection fraction (LVEF) of less than 40%. Conversely, data from the International REPORT-HF registry shows that in Indonesia, and Thailand, the distribution of heart failure types is 59% HFrEF (heart failure with reduced ejection fraction), 18% HFmrEF (heart failure with mid-range ejection fraction), and 23% HFpEF (heart failure with preserved ejection fraction). Additionally, the NHFR (National Heart Failure Registry of India) reports that HFrEF is the most common classification in South Asia, affecting 65% of patients, followed by HFmrEF at 22% and HFpEF at 13%.
Moreover, government initiatives across Southeast Asia play a crucial role in enhancing access to cardiac pacemakers and improving overall cardiovascular care. The governments are upgrading healthcare infrastructure and modernizing hospitals to include advanced cardiac units, improving access to pacemaker treatments. Initiatives like the Philippines' Universal Health Care (UHC) Law enhance coverage and reduce financial barriers, making advanced cardiac care more accessible to a wider population.
South East Asia Pacemakers Market Report Highlights:
- The external pacemakers segment held the largest share of more than 50.0% in 2023 due to their widespread use is due to their versatility, ease of application, and the immediate, adjustable support they offer.
- The conventional pacemakers segment held the largest share of around 60.0% in 2023. These devices have a long track record of effectiveness in treating bradycardia (slow heart rate) and other arrhythmias.
- In 2023, the congestive heart failure (CHF) segment dominated the market, capturing a significant 33.18% share.
- Hospitals & cardiac centers held the largest share of 42.27% in 2023. The availability of advanced diagnostic tools, surgical facilities, and post-operative care makes hospitals the preferred setting for pacemaker procedures.
Product Code: GVR-4-68040-419-7
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.2.1. Information Procurement
- 1.3. Information or Data Analysis
- 1.4. Methodology
- 1.5. Research Scope and Assumptions
- 1.6. Market Formulation & Validation
- 1.6.1. Country Market : CAGR Calculation
- 1.7. Country Based Segment Share Calculation
- 1.8. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Regional Insights
- 2.4. Competitive Insights
- 2.5. Southeast Asia Pacemakers Market Snapshot
- 2.6. Southeast Asia Pacemakers Market Segment Snapshot
- 2.7. Southeast Asia Pacemakers Market Competitive Landscape Snapshot
Chapter 3. Southeast Asia Pacemakers Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising prevalence of cardiovascular diseases (CVD)
- 3.2.1.2. Favorable reimbursement policies
- 3.2.1.3. Technological advancements
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Stringent regulation and approvals
- 3.2.2.2. Product Recalls
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.2.1. Market Driver Analysis
- 3.3. Southeast Asia Pacemakers Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.1. Industry Analysis - Porter's
Chapter 4. Southeast Asia Pacemakers Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Southeast Asia Pacemakers Market: Product Movement Analysis, 2023 & 2030 (USD Million)
- 4.3. Implantable Southeast Asia Pacemakers
- 4.3.1. Implantable Southeast Asia Pacemakers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Single Chamber
- 4.3.2.1. Single Chamber Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Dual Chamber
- 4.3.3.1. Dual Chamber Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.4. Biventricular Chamber
- 4.3.4.1. Biventricular Chamber Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. External Southeast Asia Pacemakers
- 4.4.1. External Southeast Asia Pacemakers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Southeast Asia Pacemakers Market: Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Southeast Asia Pacemakers Market: Type Movement Analysis, 2023 & 2030 (USD Million)
- 5.3. MRI Compatible Southeast Asia Pacemakers
- 5.3.1. MRI Compatible Southeast Asia Pacemakers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Conventional Southeast Asia Pacemakers
- 5.4.1. Conventional Southeast Asia Pacemakers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Southeast Asia Pacemakers Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Southeast Asia Pacemakers Market: Application Movement Analysis, 2023 & 2030 (USD Million)
- 6.3. Arrhythmias
- 6.3.1. Arrhythmias Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. Atrial Fibrillation
- 6.3.2.1. Atrial Fibrillation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Heart Block
- 6.3.3.1. Heart Block Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. Long QT Syndrome
- 6.3.4.1. Long QT Syndrome Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Congestive Heart Failure
- 6.4.1. Congestive Heart Failure Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Others
- 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Southeast Asia Pacemakers Market: End-use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Southeast Asia Pacemakers Market: End-use Movement Analysis, 2023 & 2030 (USD Million)
- 7.3. Hospitals & Cardiac Centers
- 7.3.1. Hospitals & Cardiac Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Ambulatory Surgical Centers
- 7.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Others
- 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Southeast Asia Pacemakers Market: Country Estimates & Trend Analysis
- 8.1. Regional Market Share Analysis, 2023 & 2030
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
- 8.5. South East Asia
- 8.5.1. Singapore
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Regulatory framework/ reimbursement structure
- 8.5.1.3. Competitive scenario
- 8.5.2. Malaysia
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Regulatory framework/ reimbursement structure
- 8.5.2.3. Competitive scenario
- 8.5.3. Philippines
- 8.5.3.1. Key country dynamics
- 8.5.3.2. Regulatory framework/ reimbursement structure
- 8.5.3.3. Competitive scenario
- 8.5.4. Thailand
- 8.5.4.1. Key country dynamics
- 8.5.4.2. Regulatory framework/ reimbursement structure
- 8.5.4.3. Competitive scenario
- 8.5.5. Indonesia
- 8.5.5.1. Key country dynamics
- 8.5.5.2. Regulatory framework/ reimbursement structure
- 8.5.5.3. Competitive scenario
- 8.5.1. Singapore
Chapter 9. Competitive Landscape
- 9.1. Recent Developments and Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. List of key distributors and channel partners
- 9.3.2. Key customers
- 9.3.3. Key company heat map analysis, 2023
- 9.4. Company Profiles
- 9.4.1. Boston Scientific Corporation
- 9.4.1.1. Company overview
- 9.4.1.2. Financial performance
- 9.4.1.3. Product benchmarking
- 9.4.1.4. Strategic initiatives
- 9.4.2. Medtronic
- 9.4.2.1. Company overview
- 9.4.2.2. Financial performance
- 9.4.2.3. Product benchmarking
- 9.4.2.4. Strategic initiatives
- 9.4.3. BIOTRONIK SE & Co. KG
- 9.4.3.1. Company overview
- 9.4.3.2. Financial performance
- 9.4.3.3. Product benchmarking
- 9.4.3.4. Strategic initiatives
- 9.4.4. MicroPort Scientific Corporation
- 9.4.4.1. Company overview
- 9.4.4.2. Financial performance
- 9.4.4.3. Product benchmarking
- 9.4.4.4. Strategic initiatives
- 9.4.5. Abbott
- 9.4.5.1. Company overview
- 9.4.5.2. Financial performance
- 9.4.5.3. Product benchmarking
- 9.4.5.4. Strategic initiatives
- 9.4.6. Lepu Medical Technology (Beijing)Co.,Ltd.
- 9.4.6.1. Company overview
- 9.4.6.2. Financial performance
- 9.4.6.3. Product benchmarking
- 9.4.6.4. Strategic initiatives
- 9.4.1. Boston Scientific Corporation
Product Code: GVR-4-68040-419-7
List of Tables
- Table 1 List of abbreviations
- Table 2 Southeast Asia Pacemakers, by Product, 2018 - 2030 (USD Million)
- Table 3 Southeast Asia Pacemakers, by Type, 2018 - 2030 (USD Million)
- Table 4 Southeast Asia Pacemakers, by Application, 2018 - 2030 (USD Million)
- Table 5 Southeast Asia Pacemakers, by End Use, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Southeast Asia Pacemakers market segmentation
- Fig. 2 Market research process
- Fig. 3 Information procurement
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Value-chain-based sizing & forecasting
- Fig. 7 Market formulation & validation
- Fig. 8 Commodity flow analysis
- Fig. 9 Market outlook (2023, USD Million)
- Fig. 10 Parent Market, 2023
- Fig. 11 Ancillary Market, 2023
- Fig. 12 Market driver relevance analysis (Current & future impact)
- Fig. 13 Market restraint relevance analysis (Current & future impact)
- Fig. 14 Porter's five forces analysis
- Fig. 15 SWOT Analysis by Factors (Political & Legal, Economic, Social and Technological)
- Fig. 16 Southeast Asia Pacemakers market: Product movement analysis
- Fig. 17 Southeast Asia Pacemakers market product outlook: Key takeaways
- Fig. 18 Implantable Southeast Asia Southeast Asia Pacemakers market, 2018 - 2030 (USD Million)
- Fig. 19 Single chamber market, 2018 - 2030 (USD Million)
- Fig. 20 Dual-chamber market, 2018 - 2030 (USD Million)
- Fig. 21 External Southeast Asia Southeast Asia Pacemakers market, 2018 - 2030 (USD Million)
- Fig. 22 Southeast Asia Pacemakers market: Type movement analysis
- Fig. 23 Southeast Asia Pacemakers market type outlook: Key takeaways
- Fig. 24 MRI compatible Southeast Asia Southeast Asia Pacemakers market, 2018 - 2030 (USD Million)
- Fig. 25 Conventional Southeast Asia Southeast Asia Pacemakers market, 2018 - 2030 (USD Million)
- Fig. 26 Southeast Asia Pacemakers market: Application movement analysis
- Fig. 27 Southeast Asia Pacemakers market application outlook: Key takeaways
- Fig. 28 Arrhythmias market, 2018 - 2030 (USD Million)
- Fig. 29 Atrial fibrillation market, 2018 - 2030 (USD Million)
- Fig. 30 Heart block market, 2018 - 2030 (USD Million)
- Fig. 31 Long QT syndrome market, 2018 - 2030 (USD Million)
- Fig. 32 Congestive Heart Failure market, 2018 - 2030 (USD Million)
- Fig. 33 Others market, 2018 - 2030 (USD Million)
- Fig. 34 Southeast Asia Pacemakers Market: End Use movement analysis
- Fig. 35 Southeast Asia Pacemakers market End Use outlook: Key takeaways
- Fig. 36 Hospitals & cardiac centers market, 2018 - 2030 (USD Million)
- Fig. 37 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
- Fig. 38 Others market, 2018 - 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.